Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B LIVINGSTON

Showing results (161-170 of 197) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancerR B Livingston, G K Ellis, J R Gralow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology GroupK Kelly, L Lovato, P A Bunn, et al.
Gynecologic Oncology|September 1, 1990
Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessmentJ M Cain, G K Ellis, C Collins, et al.
Cancer Research|January 1, 1994
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancerM L Disis, E Calenoff, G McLaughlin, et al.
The New England Journal of Medicine|November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology GroupS M Keller, S Adak, H Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot studyC W Taylor, J Crowley, S K Williamson, et al.
Cancer|February 1, 1978
Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapyA U Buzdar, C K Tashima, G R Blumenschein, et al.
Cancer|April 1, 1987
Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancerR B Livingston, S Schulman, B R Griffin, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1993
Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trialV W Rusch, K S Albain, J J Crowley, et al.
Cancer|November 7, 2000
Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinomaA R Yuen, G Zou, A T Turrisi, et al.
Pageof 20

Showing results (161-170 of 197) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancerR B Livingston, G K Ellis, J R Gralow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology GroupK Kelly, L Lovato, P A Bunn, et al.
Gynecologic Oncology|September 1, 1990
Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessmentJ M Cain, G K Ellis, C Collins, et al.
Cancer Research|January 1, 1994
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancerM L Disis, E Calenoff, G McLaughlin, et al.
The New England Journal of Medicine|November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology GroupS M Keller, S Adak, H Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot studyC W Taylor, J Crowley, S K Williamson, et al.
Cancer|February 1, 1978
Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapyA U Buzdar, C K Tashima, G R Blumenschein, et al.
Cancer|April 1, 1987
Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancerR B Livingston, S Schulman, B R Griffin, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1993
Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trialV W Rusch, K S Albain, J J Crowley, et al.
Cancer|November 7, 2000
Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinomaA R Yuen, G Zou, A T Turrisi, et al.
Pageof 20